SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Apricus Biosciences

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Mirror Image8/11/2015 10:30:50 AM
  Read Replies (1) of 2026
 
New Corporate Presentation

sec.gov

Finally a graph were we can see units sold in Europe these past quarters. Looks like I was off on the number of units I had estimated so far, but "somehow" ( not sure what the math equation is at this point ) the royalty that Apricus receives looks closer to $2+ than it does to $1.50. There is no exact relation between the amount of royalty revenue booked in the 10Q's so far versus the units sold stated on this graph. This is especially noticeable in the Q4 2014 versus Q1 2015 numbers.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext